Cancer isn’t going to cure itself.

People like you who feel the impact that cancer has on our loved ones.

People like you who know that supporting cancer research is the only viable option for battling this disease.

Will you continue to support our team that is on the forefront of fighting cancer?

Sarcoma represents 1 percent of all adult cancers and nearly 15 percent of all childhood cancers. However, it is often diagnosed when it has become advanced. While sarcoma can be treated by surgery, chemotherapy and/or radiation, up to 50 percent of cases are entirely resistant to all treatments, thus the extreme need for new therapeutic approaches.

Sarcoma – liposarcoma accounts for 40 percent of all human sarcomas.

Dr. Pollock and his lab team are invested in a multitude of projects, including one that involves the most common subtype of sarcoma – liposarcoma – which accounts for 40 percent of all human sarcomas.

They have identified the genetic markers of this cancer that are allowing them to study new molecular-level treatments. This precision medicine breakthrough is not just sarcoma-related; it has a rippling impact on research conducted for other types of cancer. By examining cancer at the molecular and genetic levels, our researchers can make discoveries that are no longer specific to just one type.

Your donation today is not merely a gift to our program. It is an investment in our future. Your support will help us continue to find and recruit top talent to our cancer program, like Dr. Pollock and his team. Your investment will allow our research team to conduct basic and translational research that is not being funded by other sources.